Cell cycle regulation of the cyclin A gene is determined by a bipartite repressor binding site in the region of the basal promoter, termed CDE-CHR, which also controls the expression of cell cycle genes upregulated in S or G 2 (such as cdc25C). The CDE ± CHR in the cyclin A promoter is recognized by both E2F complexes and CDF-1, but the contribution of each of these factors in cell cycle regulation is unknown. In the present study, we have introduced mutations into the cyclin A promoter which lead to either a loss or enhancement of E2F binding, while having only marginal eects on the interaction with CDF-1. Unlike mutants de®cient for CDF-1 binding, promoter variants lacking E2F binding showed an unchanged repression in G 0 , thus identifying CDF-1 as the principal repressor of the cyclin A gene. The same mutants did show, however, a delayed derepression while a mutation leading to increased E2F binding resulted in premature up-regulation. These ®ndings clearly suggest that E2F contributes to the correct timing of cyclin A transcription, presumably by acting as an anti-repressor. In agreement with this conclusion, we ®nd that the cyclin A promoter only poorly interacts with E2F-4, which is the major E2F family member in G 0 cells, while a clear binding is seen with E2F-1 and -3, which are up-regulated in late G 1 .
Introduction
Cyclin A is the regulatory subunit of cyclin dependent kinases acting in the S-and M-phases of the cell cycle. Concomitant with its phase-speci®c function, the cyclin A is periodically transcribed. Cyclin A mRNA levels increase at the G 1 /S boundary and reach peak levels in S-phase (Pines and Hunter, 1990) . The short promoter fragment of the cyclin A gene has been shown to harbor most, if not all, regulatory elements required for cell cycle-regulation and ecient transcription (Henglein et al., 1994; Zwicker et al., 1995b; Huet et al., 1996) . These elements comprise two contiguous repressor binding sites interacting with dierent complexes, i.e. E2F and CDF-1 (Schulze et al., 1995; Zwicker et al., 1995b; Liu et al., 1997; Zerfass-Thome et al., 1997) . Occupation of these repressor elements is thought to interfere with the transactivation function of factors upstream, including the CAAT-box binding factor NF-Y/CBF, members of the Sp1 family and factors of the diverse group of ATF/CREB/CREM transcriptional regulators (Desdouets et al., 1995; Nakamura et al., 1995; Yoshizumi et al., 1995; Zwicker et al., 1995b) . Members of the latter group have also been implicated in the regulation of the cyclin A promoter by cAMP during the cell cycle (Desdouets et al., 1995) as well as in the modulation of transcription by cell adherence (Yoshizumi et al., 1995) .
E2F is a heterodimeric transcription factor composed of members of the E2F and DP multi-gene families (Nevins, 1992; MuÈ ller, 1995; La Thangue, 1996) . Transcriptional activation by E2F is modulated during the cell cycle by pocket proteins of the pRb family. E2F is repressed in G 0 and early G 1 , but during cell cycle progression cyclin dependent kinases eect the dissociation of the inhibitory E2F-pocket protein complexes. This dissociation generates transcriptionally active`free E2F' and leads to the activation of E2F-regulated genes (Nevins, 1992; MuÈ ller, 1995; La Thangue, 1996) . It has become clear, however, that in many cases E2F binding sites (E2F-BSs) interact with transcriptional repressors (Zwicker and MuÈ ller, 1997) . This has ®rst been demonstrated for the mouse B-myb gene, where mutation of the E2F-BS leads to a dramatically increased activity selectively in G 0 and consequently to a loss of cell cycle regulation (Lam and Watson, 1993; Lam et al., 1994) . Other examples in this context are the promoters of E2F-1 (Hsiao et al., 1994; Johnson et al., 1994) , pRb (Shan et al., 1994) , p107 (Zhu et al., 1995) , histone H2A (Oswald et al., 1996) and orc1 (Ohtani et al., 1996) , where mutations of E2F-BSs also abrogate repression and cell cycle regulation.
The analysis of genes that are expressed at later stages of the cell cycle (Lucibello et al., 1995; Zwicker et al., 1995b) , like cdc25C, cyclin A and cdc2, led to the discovery of a bipartite cell cycle-regulated transcriptional repressor element. This motif consist of the`cell cycle dependent element' (CDE), which resembles an E2F-BS, and a directly adjacent motif, the`cell cycle genes homology region' (CHR). In vivo footprinting of the cdc25C, cyclin A and cdc2 promoters showed that both elements are only occupied when the respective gene is not transcribed, and mutation of either the CDE or the CHR abolishes repression in G 0 (Lucibello et al., 1995; Zwicker et al., 1995b) . The repressor interacting with the CDE-CHR in the cdc25C, cyclin A and cdc2 promoters in a cell cycle-dependent fashion has been identi®ed and termed CDF-1 (Liu et al., 1997) . CDF-1 is clearly distinct from E2F not only because of its bipartite binding site (CDE-CHR), but also with respect to its structure and regulation. Thus, CDF-1 does not cross-react with antibodies directed against any of the known E2F family members, it does not contain DP-1 (or other DP family members) and it does not form a complex with pocket proteins in nuclear extracts (Liu et al., 1997) . As shown by DMS protection footprinting, CDF-1 contacts the CDE in the major groove and the CHR in the minor groove, both in vivo (Zwicker et al., 1995b) and in vitro (Liu et al., 1997) .
As mentioned above, the CDE/CHR in the cyclin A promoter is recognized by both CDF-1 (Liu et al., 1997) and E2F complexes (Schulze et al., 1995; Zwicker et al., 1995b; Zerfass-Thome et al., 1997) . It has also been shown that ectopic E2F can induce the cyclin A promoter (DeGregori et al., 1995; Schulze et al., 1995) . However, since the cyclin A promoter is upregulated later than B-myb (which contains a bona ®de E2F-BS), but earlier than cdc25C (which interacts only with CDF-1), it is unclear what the actual role of these factors in the regulation of the cyclin A promoter is. In the present study, we addressed this question mainly by a structure-function approach. By introducing point mutations into the CDE of the cyclin A promoter we were able to generate promoter variants that how a dramatically decreased or increased E2F binding relative to the interaction with CDF-1. These mutants show an unchanged repression in G 0 , indicating that E2F binding is dispensable. On the other hand, the loss of CDF-1 binding due to a mutation in the CHR has been shown to result in derepression in G 0 (Zwicker et al., 1995b; Liu et al., 1997) . Therefore, CDF-1 is likely to be the principal repressor of the cyclin A gene. The modulation of E2F binding did lead, however, to altered cell cycle kinetics with higher levels of E2F binding causing earlier upregulation of transcription. Our observations suggest that E2F contributes to the correct timing of cyclin A transcription by acting as an anti-repressor.
Results

Interaction of the cyclin A CDE with E2F
We ®rst sought to assess the anity of E2F for the cyclin A CDE by comparing the binding of recombinant E2F-1/DP-1 (rE2F) complex with CDEs or E2F binding sites (E2F-BSs) from other promoters. As expected, a strong interaction was seen with the B-myb E2F-BS in an electrophoretic mobility shift assay (EMSA) (Figure 1 ), which is in agreement with previous data . In contrast, no interaction with rE2F was seen with the cdc25C CDE which interacts speci®cally with CDF-1 (Liu et al., 1997) . Both, the cyclin A and the cdc2 CDE showed a clear binding to rE2F, but this interaction was considerably weaker as compared to the B-myb E2F-BS. An interaction of both promoter elements with E2F in nuclear extracts has previously been shown (Lam and Watson, 1993; Schulze et al., 1995; Tommasi and Pfeifer, 1995; Zwicker et al., 1996; Zerfass-Thome et al., 1997) , but from the data obtained in the present study we can conclude that the cyclin A CDE does not represent a high anity E2F-BS. Since the cyclin A CDE-CHR interacts with CDF-1 as eciently as with the`classical' cdc25C motif (Liu et al., 1997) , these ®ndings provided a ®rst hint that CDF-1 might play a more important role in repression than E2F complexes.
Abrogation of E2F binding does not aect repression of the cyclin A promoter
We next analysed whether an interaction of the cyclin A promoter CDE with E2F complexes is required for the repression of transcription in G 0 cells. To this end, we analysed a set of CDE mutants for interaction with E2F and CDF-1 in order to screen for promoter variants with altered E2F binding properties relative to their interaction with CDF-1. Three such variants could be identi®ed: while no E2F binding was detectable with C2A9 and C2G4A9 in the presence of an unchanged interaction with CDF-1, mutant G4 showed a strongly increased anity for E2F (Figure 2a and b). When these promoter constructs were analysed in a functional assay in vivo, wild-type-like repression in G 0 was observed with all three constructs (Table 1) . These data strongly suggest that the extent or loss of E2F-binding to the cyclin A promoter does not in¯uence its repression in G 0 cells, establishing CDF-1 as the principal repressor of the cyclin A gene.
The cyclin A CDE interacts only weakly with E2F-4, the major family member in G 0 cells
The observations made above raise the question why the E2F complexes present in G 0 /early G 1 cells, which contain mainly E2F-4, apparently have no eect on the cyclin A promoter. We therefore analysed the interaction of various E2F family members with the cyclin A CDE using HeLa cell nuclear extracts in EMSAs (Figure 3a) . The individual E2F proteins were identi®ed by member-speci®c antibodies. HeLa cells contain three discernable DNA-binding E2F complexes, E2F-1/DP-1, E2F-3/DP-1 and E2F-4/DP-1, which can, for instance, be visualized with the B-myb promoter E2F-BS . The cyclin A CDE, however, showed a detectable interaction only with E2F-1 and E2F-3 complexes. We next asked the question why the cyclin A CDE diers in its ability to interact with individual E2F family members from that of the B-myb E2F-BS. This analysis showed that a single nucleotide determines the eciency of interaction with E2F-4/DP-1: exchanging the ®rst C in the cyclin A CDE to a G (as in B-myb) rendered the cyclin A element able to interact with E2F-4 as eciently as with E2F-1 or E2F-3 ( Figure  3b ). This is the G4 mutant which showed increased E2F binding in Figure 2b .
E2F binding shifts the kinetics of cell cycle regulation
In order to investigate a potential role for E2F in cyclin A promoter regulation at later stages of the cell cycle, we analysed the activity of the mutant cyclin A promoter constructs displaying altered anities for E2F (Figure 2 and 3b) during cell cycle progression of serum-stimulated NIH3T3 cells. The kinetics in Figure  4 demonstrate that all three promoter mutants diered in their patterns of cell cycle regulation from that seen with the wild-type cyclin A promoter. Thus, mutants C2A9 and C2G4A9 were induced later in the cell cycle 
E2F-4 a b Figure 3 Interaction of the cyclin A promoter CDE with de®ned E2F family members in HeLa nuclear extract. Binding reactions were performed in the presence of the indicated antibodies using either the wild-type cyclin A promoter sequence (a) or mutant G4 (b) as the probe (see Figure 2a for sequences). Complex formation was analysed by EMSA and in this respect resembled the cdc25C promoter, while mutant G4 was upregulated earlier than the wildtype promoter, thus mimicking B-myb regulation. These ®ndings strongly suggest that a loss of E2F binding leads to a delay of the onset of transcription, while an increased anity for E2F results in premature transcriptional up-regulation. The increased anity of the G4 mutant for E2F-4 complexes is in perfect agreement with this conclusion, since free E2F-4 is generated in mid-G1, i.e. prior to E2F-1 and -3 (Sardet et al., 1995) . These results are in line with the hypothesis that free E2F-1 and -3 complexes, which are found in late G 1 , compete with CDF-1 binding to the cyclin A promoter, thus leading to derepression around S phase entry. The interaction of E2F with the cyclin A CDE might also contribute to promoter activity through transactivation, since the G4 construct showed a slightly increased activity in serum-stimulated cells as compared to the wild-type promoter (Table 1) .
Discussion
The cyclin A promoter has previously been shown to be under negative transcriptional regulation in G 0 /early G 1 cells (Schulze et al., 1995; Zwicker et al., 1995a; Huet et al., 1996) . The promoter region responsible for cell cycle-regulated repression has been identi®ed and termed CDE-CHR (Zwicker et al., 1995a) , CCRE (Huet et al., 1996) or`variant E2F site' (Schulze et al., 1995) . It has been shown that this region of the promoter can interact with dierent transcription factors, E2F (Zerfass-Thome et al., 1997) and CDF-1 (Liu et al., 1997) , but the precise role of these factors in gene regulation has been elusive. In the present study, we have addressed this question mainly by establishing correlations between the binding of E2F and CDF-1 to the cyclin A promoter CDE-CHR region and the cell cycle regulation of transcription. Taken together, our observations suggest that the kinetics of cyclin A regulation have three components: (i) the repression by CDF-1 in G 0 and early-mid G 1 , (ii) the competition with free E2F in late G 1 /S leading to anti-repression and thus inducing the onset of transcription, and (iii) the subsequent inactivation of CDF-1 in S/G 2 (Zwicker et al., 1995b; Liu et al., 1997) leading to maximal levels of gene expression (see model in Figure 5 ).
That CDF-1 rather than E2F is the repressor of the cyclin A promoter is suggested by a number of observations: (i) The anity of E2F for the cyclin A CDE is low compared to promoters harboring E2F-BSs, such as B-myb ( Figure 1) ; (ii) Repression of the cyclin A promoter is critically dependent on the CHR (Zwicker et al., 1995a) , and changing the sequence of the cyclin A CHR to that of the B-myb promoter abolishes repression (our unpublished observation). In agreement with this result, the cyclin A CHR is identical to that of the cdc25C gene, which interacts with CDF-1 (Liu et al., 1997) , but not with E2F ( Figure 1) ; (iii) Mutations of the cyclin A CDE, which lead to a dramatic decrease (or even abolition as in C2A9) of E2F binding without noticeably altering the interaction with CDF-1, do not aect repression of the cyclin A promoter in G 0 cells to any detectable extent (Figure 2 ; Table 1 ); (iv) The cyclin A promoter interacts with E2F-1 and E2F-3 complexes in HeLa and NIH3T3 nuclear extracts, but not with E2F-4 under the identical conditions (Figure 3a) . However, cells in G 0 contain only E2F-4 complexes at detectable levels (Sardet et al., 1995) , making a role for E2F in repression highly questionable. The latter ®ndings are in apparent contrast to a report describing an interaction of the cyclin A promoter with a p107- However, the E2F protein(s) in this complex were not identi®ed, and the level of these complexes in G 0 cells relative to CDF-1 cannot be judged. It is possible that the authors employed an extremely sensitive assay, so that very low levels of complexes could be detected which, however, may not be biologically relevant. In agreement with this notion, we were able to observe binding of E2F-4/DP-1 to the cyclin A CDE when high concentrations of recombinant proteins were used for EMSA (our unpublished observations).
While it seems clear that E2F plays no signi®cant role in repression of the cyclin A promoter in G 0 /G 1 cells, several lines of evidence suggest that E2F complexes have a function later in the cell cycle: (i) A clear interaction of the cyclin A CDE could be detected with E2F-1 and E2F-3, which are upregulated in late G 1 (Figure 3a) . At this stage of the cell cycle complex formation of E2F with the CDE is comparable to the binding of CDF-1 (data not shown); (ii) Promoter variants with mutations in the CDE leading to a decreased interaction with E2F ( Figure 2) show a delayed derepression (Figure 4) . In contrast, the G4 mutant, which exhibits increased E2F binding (Figure  2) , mainly due to gaining the ability to bind E2F-4 (Figure 3b ), is upregulated prematurely (Figure 4) . These results clearly suggest that E2F binding in¯uences the timing of derepression; (iii) Previous studies have shown that the overexpression of E2F-1 leads to an upregulation of the cyclin A gene (DeGregori et al., 1995; Schulze et al., 1995) . It is likely that this eect of E2F-1 overexpression can be explained in the same way as the eect of the G4 mutation.
The most plausible interpretation for these observations is that E2F acts as an anti-repressor on the interaction of CDF-1 with the CDE-CHR in the cyclin A promoter. This would oer an explanation; (i) for the induction of the cyclin A gene by ectopic E2F expression (DeGregori et al., 1995; Schulze et al., 1995) ; (ii) for the earlier derepression of the cyclin A promoter by increasing the anity for E2F (mutant G4); and (iii) for the delay in up-regulation of promoter mutants showing decreased E2F binding (mutants C2A9 and C2G4A9) . This model would also explain why the cdc25C promoter is upregulated later than the cyclin A gene (Zwicker et al., 1995b ) (see also Figure 4 ): The cdc25C promoter is regulated by CDF-1 only, so that its derepression is solely dependent on its inactivation in S/ G 2 (see model in Figure 5 ). In the case of the cyclin A gene, the same mechanism is operational, but competition with E2F for DNA-binding would lead to an earlier dissociation at least of a fraction of CDF-1 from its cognate DNA binding site ( Figure 5 ). Such a scenario is also supported by the fact that the derepression of the cyclin A gene directly follows the up-regulation of E2F in late G 1 (MuÈ ller, 1995) .
The competition of E2F and CDF-1 for DNA binding can at present not be directly investigated in vitro due to the neccessity of a large excess of the DNA probe in the EMSA reaction. This experiment has to await the availability of recombinant CDF-1, so that in vitro binding reactions can be carried out at a low ratio of probe:protein. However, the evidence obtained in the present study taken together with previous results strongly supports the idea of E2F acting as an antirepressor at the cyclin A CDE-CHR motif. (Zwicker et al., 1995b; Liu et al., 1997) leading to maximum levels of gene expression
The interplay between dierent E2F family members and CDF-1 points to a delicate regulatory network determining the timing of cell cycle-regulated gene expression. Taken all available data into account, it seems possible to distinguish at least three dierent categories of genes that are regulated by transcriptional repression. The genes induced ®rst during cell cycle progression, such as B-myb, are repressed by E2F-4-pocket protein complexes (Lam and Watson, 1993; Lam et al., 1994) . Free E2F-4, which is generated in mid-G 1 , acts as an anti-repressor, and later, when E2F-4 becomes cytoplasmic (MuÈ ller et al., 1997), free E2F-1, -2 and 3 act as anti-repressors and perhaps as activators. Genes induced around S phase entry, exempli®ed by cyclin A, are unable to interact eciently with E2F-4, but bind to CDF-1 with high anity (Zwicker et al., 1995b; Liu et al., 1997) . The interaction with CDF-1 is counteracted by free E2F-1, -2 and -3, once these proteins become upregulated in late G 1 (Sardet et al., 1995) , leading to anti-repression, before CDF-1 is inactivated later in S/G 2 (Zwicker et al., 1995b; Liu et al., 1997) . The third group of genes is induced in S/G 2 , such as cdc25C, as is regulated by CDF-1 only since their repressor elements are unable to interact with E2F (Zwicker et al., 1995a; Liu et al., 1997) . It is likely that other mechanisms exist, since some of the known cell cycle genes clearly do not fall into these groups (Zwicker and MuÈ ller, 1997) . It will also be interesting to see whether CDF-1 is only one member of a multi-gene family of repressors acting on dierent genes and/or at dierent stages of the cell cycle, a scenario that would add another level of complexity. These considerations also suggest that we are much further away from understanding cell cycleregulated transcription than might have been anticipated after the discovery of the E2F pathway.
Materials and methods
Cell culture, DNA transfection and luciferase assays NIH3T3 cells were cultured in Dulbecco-Vogt modi®ed Eagle medium (DMEM) supplemented with 10% fetal calf serum, penicillin and streptomycin. HeLa cells were grown in DMEM plus 5% newborn calf serum. NIH3T3 cells were transfected by the DEAE dextran technique as described (Lucibello et al., 1995) . For synchronization in G 0 , cells were maintained in serum free medium for 2 days 12 h after transfection and restimulated with 10% FCS for the time periods indicated in Figure 4 . Determination of luciferase activities and standardization of results were performed as published (Lucibello et al., 1995) .
Luciferase constructs
The cdc25C and B-myb promoter-driven luciferase constructs have been described elsewhere (Lucibello et al., 1995; Zwicker et al., 1995b; Liu et al., 1996) . Mutations were introduced by PCR strategies as described (Zwicker et al., 1995b) . All PCR-ampli®ed fragments were veri®ed by DNA sequencing.
Fractionation of nuclear extract
Nuclear extracts were prepared from HeLa suspension cultures in high salt extraction buer (Dignam et al., 1983) in the presence of the protease inhibitors leupeptin (50 ng/ ml), pepstatin A (5 mg/ml), and aprotinin (80 ng/ml) and applied to a EDF-Sepharose (Merck, Darmstadt, Germany) column in a buer containing 50 mM Tris-HCl, pH 7.5, 10% glycerol and 3 mM DTT. Elution was performed by a gradient of 0.1 to 1 m NaCl. CDF-1 eluted at a salt concentration of 150 mM, while all E2F complexes eluted at 300 ± 400 mM.
Electrophoretic mobility shift assay (EMSA)
EMSA conditions and oligonucleotide probes have been published previously . The sequences of the cyclin A promoter mutants are indicated in Figure 2a . The recombinant E2F and DP-1 proteins and their use in EMSAs has been described elsewhere . Antibodies speci®c for E2F-1 (KH-95) and E2F-3 (N-20) or E2F-4 (C-108) and used for supershifts were purchased from Santa-Cruz Biotechnology.
